A Combination of Muramylpeptides from Gram-Negative Bacteria Corrects Hematological and Immunological Disorders Induced by Cyclophosphamide


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We have studied the effect of a combination of three natural muramylpeptides containing a meso-diaminopimelic acid residue (polyramyl) on the subpopulations of circulating T cells, spleen morphology, and leukocyte level in the blood of C57Bl/6 mice with cyclophosphamideinduced immunosuppression. Intraperitoneal injections of cyclophosphamide in a dose of 100 mg/kg on days 1, 3, 5, and 7 of the experiment reduced leukocyte count and the relative number of CD4+ T cells in the blood, and also depleted the cellular composition of splenic white pulp on day 10. Subcutaneous injections of polyramyl in a dose of 200 μg/mouse on days 8 and 9 practically completely restored blood leukocytes count and morphology of the splenic white pulp. Moreover, administration of polyramyl induced marked tendency to increase in the relative number of CD4+ T cells and CD4/CD8 ratio in mice with cyclophosphamideinduced immunosuppression.

About the authors

M. V. Kiselevskii

Laboratory of Cellular Immunity, N. N. Blokhin National Medical Research Center, Ministry of Health of the Russian Federation

Author for correspondence.
Email: kisele@inbox.ru
Russian Federation, Moscow

N. Yu. Anisimova

Laboratory of Cellular Immunity, N. N. Blokhin National Medical Research Center, Ministry of Health of the Russian Federation

Email: kisele@inbox.ru
Russian Federation, Moscow

S. M. Sitdikova

Laboratory of Cellular Immunity, N. N. Blokhin National Medical Research Center, Ministry of Health of the Russian Federation

Email: kisele@inbox.ru
Russian Federation, Moscow

F. V. Donenko

Laboratory of Cellular Immunity, N. N. Blokhin National Medical Research Center, Ministry of Health of the Russian Federation

Email: kisele@inbox.ru
Russian Federation, Moscow

S. F. Popilyuk

CORUS Pharma Company, Resident of Biomedical Technologies Cluster, Skolkovo Foundation

Email: kisele@inbox.ru
Russian Federation, Skolkovo, Moscow Region

V. L. L’vov

Laboratory No. 16 for Preparatory Biochemistry of Antigens, State Research Center Institute of Immunology, Federal Medial-Biological Agency

Email: kisele@inbox.ru
Russian Federation, Volokolamsk

O. V. Kalyuzhin

Department of Clinical Immunology and Allergology, I. M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of the Russian Federation

Email: kisele@inbox.ru
Russian Federation, Moscow


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies